Do you all think the presentation in May might lead to negative data? I know the company has come out with good results here lately. But I'm assuming they would not present their findings at such an important conference only to reveal bad results? If the results were not as they hoped for, would they even bother attending? How would positive results affect the share price or would it all? Sorry in advance for all the questions but I'm new to biotech stocks but am very excited about the possibilities of this stock.